Allmed Solutions Ltd (ALMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Allmed Solutions Ltd (ALMD) has a cash flow conversion efficiency ratio of -0.241x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-6.77 Million ≈ $-18.14K USD) by net assets (ILA28.07 Million ≈ $75.25K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Allmed Solutions Ltd worth for the company's overall valuation and market capitalisation.
Allmed Solutions Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Allmed Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Allmed Solutions Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Allmed Solutions Ltd ranked by their cash flow conversion efficiency. Explore Allmed Solutions Ltd (ALMD) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Curanex Pharmaceuticals Inc Common Stock
NASDAQ:CURX
|
-0.643x |
|
Nyrstar NV
BR:NYR
|
0.000x |
|
Magontec Ltd
AU:MGL
|
0.008x |
|
Focus Dynamics Group Bhd
KLSE:0116
|
0.047x |
|
ECP Emerging Growth Ltd
AU:ECP
|
-0.023x |
|
Aqua Metals Inc
NASDAQ:AQMS
|
-0.276x |
|
Fiberweb (India) Limited
NSE:FIBERWEB
|
0.085x |
|
Viet Brand Invest JSC
VN:ABR
|
N/A |
Annual Cash Flow Conversion Efficiency for Allmed Solutions Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Allmed Solutions Ltd from 2008 to 2025. View Allmed Solutions Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA28.07 Million ≈ $75.25K |
ILA-12.08 Million ≈ $-32.39K |
-0.430x | -125.38% |
| 2024-12-31 | ILA42.02 Million ≈ $112.65K |
ILA-8.03 Million ≈ $-21.51K |
-0.191x | -249.81% |
| 2023-12-31 | ILA55.97 Million ≈ $150.06K |
ILA7.14 Million ≈ $19.13K |
0.127x | +167.35% |
| 2022-12-31 | ILA53.96 Million ≈ $144.67K |
ILA-10.21 Million ≈ $-27.39K |
-0.189x | -80.81% |
| 2021-12-31 | ILA52.31 Million ≈ $140.25K |
ILA-5.48 Million ≈ $-14.68K |
-0.105x | +42.08% |
| 2020-12-31 | ILA48.77 Million ≈ $130.76K |
ILA-8.82 Million ≈ $-23.64K |
-0.181x | +17.04% |
| 2019-12-31 | ILA56.58 Million ≈ $151.69K |
ILA-12.33 Million ≈ $-33.05K |
-0.218x | +55.35% |
| 2018-12-31 | ILA32.83 Million ≈ $88.02K |
ILA-16.02 Million ≈ $-42.96K |
-0.488x | -2.71% |
| 2017-12-31 | ILA38.76 Million ≈ $103.91K |
ILA-18.42 Million ≈ $-49.38K |
-0.475x | -5.08% |
| 2016-12-31 | ILA38.19 Million ≈ $102.39K |
ILA-17.27 Million ≈ $-46.30K |
-0.452x | -28.55% |
| 2015-12-31 | ILA45.13 Million ≈ $120.98K |
ILA-15.87 Million ≈ $-42.56K |
-0.352x | +40.54% |
| 2014-12-31 | ILA32.16 Million ≈ $86.22K |
ILA-19.03 Million ≈ $-51.01K |
-0.592x | -33.36% |
| 2013-12-31 | ILA30.22 Million ≈ $81.02K |
ILA-13.41 Million ≈ $-35.94K |
-0.444x | -1.62% |
| 2012-12-31 | ILA67.29 Million ≈ $180.40K |
ILA-29.37 Million ≈ $-78.75K |
-0.437x | -141.17% |
| 2011-12-31 | ILA72.36 Million ≈ $193.98K |
ILA-13.10 Million ≈ $-35.11K |
-0.181x | +43.58% |
| 2010-12-31 | ILA26.29 Million ≈ $70.47K |
ILA-8.43 Million ≈ $-22.61K |
-0.321x | -102.04% |
| 2009-12-31 | ILA10.83 Million ≈ $29.04K |
ILA-1.72 Million ≈ $-4.61K |
-0.159x | +61.70% |
| 2008-12-31 | ILA14.19 Million ≈ $38.04K |
ILA-5.88 Million ≈ $-15.77K |
-0.415x | -- |
About Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more